FDA Rejects ViroPharma Testing Plea, OKs Generic Vancocin
ViroPharma Inc. said Tuesday that the U.S. Food and Drug Administration rejected its citizen petition challenging the approval of laboratory testing instead of human testing for generic versions of the gastrointestinal...To view the full article, register now.
Already a subscriber? Click here to view full article